The Novo Nordisk Haemophilia Foundation (NNHF) is based in Zurich, Switzerland, with world-wide activities focused on improving access to care for people with haemophilia and allied bleeding disorders.

We want to focus our activities on making an impact that is sustainable after our funding ends. The initiatives we support take place in developing countries, preferably in the low, lower middle and upper middle income categories, as defined by the Organisation for
Economic Co-operation and Development’s Development Assistance Committee (OECD DAC) list.

NNHF cooperates with partners in these countries, such as health ministries and authorities, non governmental and patient organisations, health care professionals, other foundations and trusts.